FAKTOR-OPTIONSSCHEIN - HALEON Share Price

Certificat

DE000MG2WHH7

Market Closed - Börse Stuttgart 09:31:03 24/05/2024 BST
10.95 EUR +5.09% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month+32.09%
1 month-11.26%
Date Price Change
24/05/24 10.95 +5.09%
23/05/24 10.42 +2.56%
22/05/24 10.16 +5.61%
21/05/24 9.62 +13.71%
20/05/24 8.46 -18.81%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 09:31 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MG2WHH
ISINDE000MG2WHH7
Date issued 24/04/2024
Strike 361.8 p
Maturity Unlimited
Parity 0.04 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.36
Lowest since issue 8.29
Spread 0.1
Spread %0.80%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.23 GBP
Average target price
3.62 GBP
Spread / Average Target
+12.07%
Consensus